Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Finasteride may improve sperm count in subfertile men with low sperm count.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

New effective scar treatments are urgently needed due to the current options' limited success.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Spironolactone plus finasteride reduces hirsutism more effectively.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Spironolactone plus finasteride works better for treating hirsutism.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

The paper concludes that understanding melanocyte development can help in insights into skin diseases and melanoma diversity.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Higher iron levels in the blood are not linked to increased hair loss in women.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Doctors have known about fungal skin infections for a long time, but only made major progress in understanding and treating them since the mid-1800s.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.